Evidence map›Paper›PMID 41404795›Full record

ReviewNucleic acids research2025

Eukaryotic translation initiation factor 4F: functional properties and physiological role.

Ekaterina Shuvalova, Walaa Al Sheikh, Alexey Shuvalov, Ilya M Terenin, Elena Alkalaeva

Abstract readReview
In one paragraph

Review in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Remodeling of mRNA by eIF4F in human translation initiation.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ekaterina ShuvalovaEngelhardt Institute of Molecular Biology, the Russian Academy of Sciences, Moscow, 119991, Russia.
Walaa Al SheikhEngelhardt Institute of Molecular Biology, the Russian Academy of Sciences, Moscow, 119991, Russia.
Alexey ShuvalovEngelhardt Institute of Molecular Biology, the Russian Academy of Sciences, Moscow, 119991, Russia.ORCID 0000-0002-0346-3794
Ilya M TereninDepartment of Experimental Medicine, University of Lund, Lund, 221 84, Sweden.ORCID 0000-0002-4459-0781
Elena AlkalaevaEngelhardt Institute of Molecular Biology, the Russian Academy of Sciences, Moscow, 119991, Russia.ORCID 0000-0003-2078-7261

Funding

Russian Science Foundation 22-14-00279
6 · The paper itself

Abstract

Successful translation requires multiple protein factors with diverse specific activities. Initiation of translation is regarded as the most tightly regulated step of this process, controlled by numerous factors. Among these is the eukaryotic initiation factor 4F (eIF4F), a protein complex composed of three subunits: the cap-binding protein eIF4E, the RNA helicase eIF4A, and the scaffolding protein eIF4G. While significant progress has been made in elucidating the structure and functions of eIF4F, several key questions remain unresolved concerning its mechanistic contributions to translational control. In this review, we discuss the roles of eIF4F in translation and its regulatory functions under diverse cellular conditions. Dysregulation of eIF4F is frequently implicated in a wide range of physiological abnormalities, confirming its critical role in the cell. We also review recent studies that position eIF4F as a global cellular regulator and expand our understanding of its role.

Indexed as

Eukaryotic Initiation Factor-4FPeptide Chain Initiation, TranslationalProtein BiosynthesisAnimalsEukaryotic Initiation Factor-4EHumansEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4F

Identifiers

PMID41404795
PMCPMC12709193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.